
AVAH Stock Forecast & Price Target
AVAH Analyst Ratings
Bulls say
Aveanna Healthcare Holdings Inc. demonstrated a robust financial performance, with revenue in the Private Duty Services segment reaching $514.4 million, reflecting a remarkable 25.6% year-over-year growth, an outcome attributed to strong execution and the successful integration of the Thrive platform. The Home Health & Hospice segment also performed well, generating $62.4 million in revenue, a 15.3% increase from the previous year, driven by significant growth in total and episodic admissions. Overall, Aveanna’s financial flexibility appears to be improving, supported by a cash flow performance that exceeds expectations and an increased revenue guidance to over $2.375 billion, indicating a positive outlook for the company's future operations.
Bears say
Aveanna Healthcare Holdings Inc faces significant challenges that contribute to a negative outlook. Key concerns include potential reimbursement pressures, difficulties in sourcing and integrating acquisitions, and slower-than-anticipated organic growth, all exacerbated by high leverage and increasing competition in the home healthcare market. Additionally, the company is experiencing labor headwinds that are projected to adversely impact adjusted EBITDA, alongside a decline in gross margins, indicating potential vulnerabilities in its financial performance and operational efficiency.
This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.
AVAH Analyst Forecast & Price Prediction
Start investing in AVAH
Order type
Buy in
Order amount
Est. shares
0 shares